Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Association of Cardiovascular Disease With Respiratory Disease
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics.
AIM2-driven inflammasome activation in heart failure
Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review